These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21156848)

  • 1. A case for prophylactic vaginal estrogen?
    Morris E; Currie H
    Menopause Int; 2010 Dec; 16(4):135. PubMed ID: 21156848
    [No Abstract]   [Full Text] [Related]  

  • 2. Topical estrogen therapy in the management of postmenopausal vaginal atrophy: an up-to-date overview.
    Al-Baghdadi O; Ewies AA
    Climacteric; 2009 Apr; 12(2):91-105. PubMed ID: 19117185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vulvovaginal complaints.
    Mehta A; Bachmann G
    Clin Obstet Gynecol; 2008 Sep; 51(3):549-55. PubMed ID: 18677149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaginal estrogen preparations for relief of atrophic vaginitis.
    Nothnagle M; Taylor JS
    Am Fam Physician; 2004 May; 69(9):2111-2. PubMed ID: 15152956
    [No Abstract]   [Full Text] [Related]  

  • 5. Vaginal atrophy. Treatment options.
    Mayo Clin Health Lett; 2014 Nov; 32(11):7. PubMed ID: 26027044
    [No Abstract]   [Full Text] [Related]  

  • 6. Vulvovaginal atrophy: new and upcoming approaches.
    Simon JA
    Menopause; 2009; 16(1):5-7. PubMed ID: 19131842
    [No Abstract]   [Full Text] [Related]  

  • 7. Estrogen and its effect on vaginal atrophy in post-menopausal women.
    Kelley C
    Urol Nurs; 2007 Feb; 27(1):40-5. PubMed ID: 17390926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrophic vaginitis.
    Stika CS
    Dermatol Ther; 2010; 23(5):514-22. PubMed ID: 20868405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. By the way, doctor. My doctor prescribed a low-dose vaginal estrogen cream, applied twice a week, for atrophic vaginitis. I've heard this dose is so low that it carries no health risk. Do you agree?
    Robb-Nicholson C
    Harv Womens Health Watch; 2007 Nov; 15(3):7. PubMed ID: 18225330
    [No Abstract]   [Full Text] [Related]  

  • 10. A randomized, placebo- and active-controlled trial of bazedoxifene/conjugated estrogens for treatment of moderate to severe vulvar/vaginal atrophy in postmenopausal women.
    Kagan R; Williams RS; Pan K; Mirkin S; Pickar JH
    Menopause; 2010 Mar; 17(2):281-9. PubMed ID: 19779382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society.
    North American Menopause Society
    Menopause; 2007; 14(3 Pt 1):355-69; quiz 370-1. PubMed ID: 17438512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estradiol vaginal inserts (Imvexxy): effective in genitourinary syndrome of menopause without increasing systemic estrogen levels.
    Paton DM
    Drugs Today (Barc); 2018 Nov; 54(11):667-677. PubMed ID: 30539166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma estrogen concentrations after oral and vaginal estrogen administration in women with atrophic vaginitis.
    Dorr MB; Nelson AL; Mayer PR; Ranganath RP; Norris PM; Helzner EC; Preston RA
    Fertil Steril; 2010 Nov; 94(6):2365-8. PubMed ID: 20466363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravaginal oestrogen and progestin administration: advantages and disadvantages.
    Cicinelli E
    Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):391-405. PubMed ID: 17981510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why the product labeling for low-dose vaginal estrogen should be changed.
    Manson JE; Goldstein SR; Kagan R; Kaunitz AM; Liu JH; Pinkerton JV; Rebar RW; Schnatz PF; Shifren JL; Stuenkel CA; Gass ML; Utian WH;
    Menopause; 2014 Sep; 21(9):911-6. PubMed ID: 25140698
    [No Abstract]   [Full Text] [Related]  

  • 16. Progress and prospects in treating postmenopausal vaginal atrophy.
    Winneker RC; Harris HA
    Clin Pharmacol Ther; 2011 Jan; 89(1):129-32. PubMed ID: 20944561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugs for menopausal symptoms.
    Med Lett Drugs Ther; 2016 Nov; 58(1507):142-145. PubMed ID: 27805574
    [No Abstract]   [Full Text] [Related]  

  • 18. [Vagifem. A new low-dosage estradiol preparation for local treatment of postmenopausal urogenital atrophy].
    Eriksen PS; Rasmussen H
    Ugeskr Laeger; 1992 Apr; 154(16):1122-4. PubMed ID: 1523727
    [No Abstract]   [Full Text] [Related]  

  • 19. Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet.
    Weisberg E; Ayton R; Darling G; Farrell E; Murkies A; O'Neill S; Kirkegard Y; Fraser IS
    Climacteric; 2005 Mar; 8(1):83-92. PubMed ID: 15804736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status.
    Gupta P; Ozel B; Stanczyk FZ; Felix JC; Mishell DR
    Menopause; 2008; 15(1):94-7. PubMed ID: 17882008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.